Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The role of bevacizumab in the treatment of ovarian cancer
Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - F...
The role of bevacizumab in the treatment of ovarian cancer ( Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - Fox Chase Cancer Center, Philadelphia, USA; Prof Nicoletta Colombo - European Institute of Oncology, Milan, Italy )
7 Feb 2011
Sarah Cannon Research Institute research developments at ASCO 2010
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute research developments at ASCO 2010 ( Dr Howard Burris, The Sarah Cannon Research Institute, Nashville )
4 Feb 2011
FIRST trial follow up results
Prof John Robertson - University of Nottingham, UK
FIRST trial follow up results ( Prof John Robertson - University of Nottingham, UK )
1 Feb 2011
SPECTRUM trial for squamous cell carcinoma of the head and neck
Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA
SPECTRUM trial for squamous cell carcinoma of the head and neck ( Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA )
31 Jan 2011
A new treatment for fractured vertebrae and the antiemetic efficacy of palonoset...
Prof Fausto Roila - Terni Hospital, Italy
A new treatment for fractured vertebrae and the antiemetic efficacy of palonosetron ( Prof Fausto Roila - Terni Hospital, Italy )
31 Jan 2011
Clinical benefits and side effects of ipilimumab in melanoma patients
Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )
31 Jan 2011
Molecular biomarkers and acquired resistance to new target agents
Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy
Molecular biomarkers and acquired resistance to new target agents ( Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy )
31 Jan 2011
CA-125 in the follow up of patients with ovarian cancer in German
Prof Christian Marth - Innsbruck Medical University, Austria
CA-125 in the follow up of patients with ovarian cancer in German ( Prof Christian Marth - Innsbruck Medical University, Austria )
24 Jan 2011
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast canc...
Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer ( Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy )
19 Jan 2011
Zoledronic acid disappointment for early breast cancer
Prof Michael Gnant - Medical University of Vienna, Austria
Zoledronic acid disappointment for early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )
19 Jan 2011
NeoALTTO trial results
Prof José Baselga – Massachusetts General Hospital Cancer Center, USA
NeoALTTO trial results ( Prof José Baselga – Massachusetts General Hospital Cancer Center, USA )
19 Jan 2011